Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Molecular Cancer Research : MCR|May 11, 2018
YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMTCorinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 17, 2026
Ro 08-2750 increases radiation-induced cytotoxicity in DLBCL by dysregulating the DNA damage responseLasse Reichstein, Timo Habig, Kathrin A Gurke Brücksken, et al.British Journal of Pharmacology|June 25, 2026
Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitisKrithika Rajeeth, Malte Roessing, Moritz Lehners, et al.Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Bcl10 controls TCR- and FcgammaR-induced actin polymerizationDaniel Rueda, Olivier Gaide, Liza Ho, et al.Leukemia|November 9, 2022
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphomaWendan Xu, Philipp Berning, Tabea Erdmann, et al.Molecular Imaging and Biology|September 5, 2019
Temporal Dynamics of Reactive Oxygen and Nitrogen Species and NF-κB Activation During Acute and Chronic T Cell-Driven InflammationJohannes Schwenck, Roman Mehling, Wolfgang M Thaiss, et al.Blood Advances|November 7, 2023
Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stressBeatriz Gomez Solsona, Heike Horn, Anja Schmitt, et al.Blood|June 9, 2023
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosisAnja Schmitt, Melanie Grimm, Nina Kreienkamp, et al.Blood|July 23, 2013
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCLHendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger, et al.Pageof 6